Entry |
|
Name |
Heparin calcium (JP18); Nadroparin calcium (INN); Calciparin; Calciparine (TN) |
Class |
Blood modifier agent
DG01950 Antithrombotic agent
DG01709 Heparin anticoagulant
|
Remark |
Therapeutic category: | 3334 |
Product (DG00150): | D02112<JP/US> D04427<JP> D03674<JP/US> D04977<JP> D03353<JP/US> |
|
Efficacy |
Anticoagulant, Antithrombin III activator, Platelet aggregation inhibitor |
Comment |
Low molecular weight heparin (LMWH)
Calcium salt of depolymerized heparin
|
Target |
|
Pathway |
hsa04610 | Complement and coagulation cascades |
|
Interaction |
|
Structure map |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AB Heparin group
B01AB01 Heparin
D04427 Heparin calcium (JP18) <JP>
B01AB06 Nadroparin
D04427 Heparin calcium (JP18) <JP>
C CARDIOVASCULAR SYSTEM
C05 VASOPROTECTIVES
C05B ANTIVARICOSE THERAPY
C05BA Heparins or heparinoids for topical use
C05BA03 Heparin
D04427 Heparin calcium (JP18) <JP>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01X OTHER OPHTHALMOLOGICALS
S01XA Other ophthalmologicals
S01XA14 Heparin
D04427 Heparin calcium (JP18) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
33 Blood and body fluid agents
333 Anticoagulants
3334 Heparins
D04427 Heparin calcium (JP18); Nadroparin calcium (INN)
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01709 Heparin anticoagulant
DG00150 Heparin
D04427 Heparin calcium
Target-based classification of drugs [BR:br08310]
Not elsewhere classified
Organismal systems
Complement and coagulation
SERPINC1 (AT3)
D04427 Heparin calcium (JP18) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D04427 Heparin calcium
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01709 Heparin anticoagulant
DG00150 Heparin
|
Other DBs |
|
LinkDB |
|